EOFLOW Co.,Ltd.

KOSDAQ 294090.KQ

EOFLOW Co.,Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 14.28

EOFLOW Co.,Ltd. Price to Sales Ratio (P/S) is 14.28 on January 14, 2025, a -26.64% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

EOFLOW Co.,Ltd. 52-week high Price to Sales Ratio (P/S) is 70.11 on May 21, 2024, which is 390.81% above the current Price to Sales Ratio (P/S).
EOFLOW Co.,Ltd. 52-week low Price to Sales Ratio (P/S) is 12.20 on December 09, 2024, which is -14.57% below the current Price to Sales Ratio (P/S).
EOFLOW Co.,Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 31.17.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

KOSDAQ: 294090.KQ

EOFLOW Co.,Ltd.

CEO	Mr. Jaejin Kim
IPO Date	Sept. 14, 2020
Location	South Korea
Headquarters	Healthcare Innovation Park Number H2102
Employees	121
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

EOFLOW Co.,Ltd. develops and provides drug delivery solutions. The company offers EOPatch, a wearable insulin pump system. EOFLOW Co.,Ltd. is based in Seongnam, South Korea.

Key trends

Past 5 years